PMEF
BLUE

Point72 Middle East FZE’s bluebird bio BLUE Stock Holding History

Point72 Middle East FZE’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,407
Closed -$268K – 1522
2023
Q3 		$268K Buy
4,407
+1,239
+39% +$87K 0.01% 954
2023
Q2 		$208K Buy
+3,168
New +$232K 0.01% 1052
2023
Q1 		– Sell
-2,205
Closed -$305K – 1671
2022
Q4 		$305K Buy
+2,205
New +$311K 0.01% 893

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GCM
Ghisallo Capital Management Boston, Massachusetts $3.63B AUM 30.51% 1-Year Est. Return

Point72 Middle East FZE's BLUE Position: Q4 2023 in Review

Point72 Middle East FZE sold out of bluebird bio (BLUE) in Q4 2023, closing a stake of 4,407 shares — an estimated $268K sold.

Point72 Middle East FZE first reported a position in BLUE in Q4 2022 and held it in 3 quarters. The position peaked at $305K in Q4 2022. 187 funds tracked by Wall St. Rank hold BLUE as of Q4 2023.

  • Point72 Middle East FZE reported no remaining bluebird bio position as of Q4 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 4,407 bluebird bio shares in Q4 2023, an estimated $268K.
  • Point72 Middle East FZE first reported a position in bluebird bio in Q4 2022 and held it in 3 quarters.
  • Point72 Middle East FZE's bluebird bio position peaked at $305K in Q4 2022.
  • 187 funds tracked by Wall St. Rank held bluebird bio as of Q4 2023.

Based on Point72 Middle East FZE's 13F filing for Q4 2023, filed 14 Feb 2024.